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irradiation induces pS3 expression in in vivo normal human skin that 
returns to undetectable basal level within 15 d [20] . As psoriatic 
patients often undergo psoralen plus ultraviolet A therapy, we 
wonder whether this could explain why p53 expression can be 
detected in some instances. It should be kept in mind that detection 
of the p53 protein does not necessarily indicate the existence of a 
mutation of the gene but can also come from a dysregularion of its 
expression. 
In conclusion, the TPS3 gene was not altered in the seven exons 
analyzed, and TP53 gene product was not detected, in psoriatic skin. 
Dysregulation of the cell-cycle process in this disease might come 
from other genes, such as still unstudied tumor-suppressor genes or 
oncogenes; we recently demonstrated a decrease in c-FOS expres-
sion in lesional psoriatic skin [21]. More studies are required to 
understand the possible involvement of oncogene and/or tumor 
suppressor genes in psoriasis. 
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ANNOUNCEMENT 
A workshop on Photoimmunology will be held in Capocaccia, near Alghero, Sardinia, Italy, 
October 8 - 10, 1993. The workshop will take place during the summerschool, entitled Photo-
biology in Medicine. 
Organizers of the Photoimmul1010gy workshop are P. Bergstresser, Th . Dubbelman, and 
BJ. Vermeer. 
The following topics will be discussed. 
1. Introduction immunology of the skin . 
2. Modulation of the immune system by UV light (antigen presentation, T-cell recognition, 
cytokine production, adhesion molecules). 
3. Genetic polymorphism of UV -induced immune suppression. 
4. Photoreceptor for UV-induced immune suppression. 
5. Effect ofUV light on infections (HIV, Herpes simplex). 
6. Clinical relevance of photoimmunology (e.g., skin cancer in immune compromised host). 
7 . Therapeutic use ofUV-induced immunosuppression (e.g., thrombocyte transfusion). 
8. Immunologic aspects of photophoresis and photodynamic therapy. 
9 . Effect of sunscreen on photoimmunological aspects. 
For registration contact B.]. Vermeer, Department of Dermatology, University Hospital, 
Leiden, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Fax: 31 71 144348. 
